Notified Body Resource Problems? We Know, Says TEAM-NB, But There Is No Easy Fix
This article was originally published in SRA
The issue of medical device notified bodies in the EU being under-resourced is one that the European Commission and the competent authorities are well aware of and the topic is expected to come up in discussions currently taking place in Brussels on the new medtech regulations.
You may also be interested in...
February sees some vitally important issues on the European Commission’s agenda, including areas where the medtech sector has been clamoring for progress in terms of clarity over the Commission's thinking and guidance documents. This year's meetings are plentiful and critical.
While the EU has selected the CND system as the basis for its nomenclature, GMDN is becoming increasingly valued on the US and international scene. How does it see its latest role panning out globally?
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.